SAN DIEGO, Feb. 6 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc., a biopharmaceutical company focused on neurological and endocrine diseases and disorders announced today that Gary Lyons, President and CEO will present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference tomorrow, Tuesday, February 7, 2006 at the Grand Hyatt Hotel in New York.
The live presentation begins at 2:20 p.m. Eastern Time (ET) / 11:20 a.m. Pacific Time (PT) with an overview of the Company’s development pipeline and research programs followed by an extended Q&A session. The presentation will be webcast and can be accessed on the Company’s website at http://www.neurocrine.com.
A replay of the webcast will be available approximately 24 hours after the presentation concludes and will be archived until Tuesday, February 21, 2006. Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software.
If you are unable to attend the webcast and would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at 858-617-7600 and ask for Claudia Woodworth or Elizabeth Foster.
Neurocrine Biosciences, Inc. is a product-based biopharmaceutical Company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, anxiety, depression, diabetes, multiple sclerosis, irritable bowel syndrome, and autoimmunity. Neurocrine Biosciences, Inc. news releases are available through the Company’s website via the Internet at http://www.neurocrine.com
Neurocrine Biosciences, Inc.
CONTACT: Claudia Woodworth or Elizabeth Foster, both of NeurocrineBiosciences, Inc., +1-858-617-7600
Web site: http://www.neurocrine.com/
